73P Association between homologous recombination repair mutations and response to pembrolizumab (pembro) plus olaparib (ola) in metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort A biomarker analysis

Autor: Yu, E., Piulats, J.M., Gravis, G., Fong, P., Todenhöfer, T., Laguerre, B., Arranz, J., Oudard, S., Massard, C., Stoeckle, M., Nordquist, L.T., Carles, J., Huang, M., Li, Y., Qiu, P., Poehlein, C.H., Schloss, C., de Bono, J.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S387-S387
Databáze: ScienceDirect